Families where FA is due to biallelic BRCA2 mutations will clearly have an increased cancer risk, but these cases are rare (<2% of all FA) and none of the families in this study had a pedigree typical of autosomal dominant breast/ovarian cancer predisposition. This evidence concerns the gene BRCA2 and ovarian cancer.